Drug used within 3 months of index date Adjusted odds ratio* p

Slides:



Advertisements
Similar presentations
Update in Prescribing and therapeutics: NSAID’s in Emergency Medicine.
Advertisements

Carol Coupland Paula Dhiman Tony Arthur Richard Morriss Julia Hippisley-Cox University of Nottingham Garry Barton University of East Anglia Antidepressant.
Department of Health and Human Services Center for Drug Evaluation and Research Review of Epidemiologic Studies on Cardiovascular Risk with Selected NSAIDs.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 71 Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen.
Cyclo-oxygenase 2 inhibitors and cardiovascular risk —where are we now? Sung-Hwan Park M.D Rheumatology, Internal Medicine Kangnam St Mary’s hospital The.
Presentations in this series 1.Introduction 2.Self-matching 3.Proxies 4.Intermediates 5.Instruments 6.Equipoise Avoiding Bias Due to Unmeasured Covariates.
Canadian Cardiovascular Society Antiplatelet Guidelines
Is low-dose Aspirin use associated with a reduced risk of colorectal cancer ? a QResearch primary care database analysis Prof Richard Logan, Dr Yana Vinogradova,
Infliximab TNF- α antagonist Watch for infections.
Analgesics for Osteoarthritis — An Update Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Exposure to bisphosphonates and risk of non-gastrointestinal cancers: nested case-control studies SAPC 2013, Nottingham Yana Vinogradova, Carol Coupland,
Non Steroidal Anti Inflammatory Drugs, Nonopioid Analgesics By S.Bohlooli, PhD.
 صدق لله العلي العظيم سورة طه الايه 114 فَتَعَالَى اللَّهُ الْمَلِكُ الْحَقُّ وَلا تَعْجَلْ بِالْقُرْآنِ مِنْ قَبْلِ أَنْ يُقْضَى إِلَيْكَ وَحْيُهُ وَقُلْ
Chapter 12 Anti-inflammatory Agents. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Nonsteroidal.
Presenter Disclosure Information
An Update on NSAID Labeling and Data Review DSaRM Advisory Committee February 10, 2006 Sharon Hertz, M.D. Deputy Director Division of Anesthesia, Analgesia,
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 18 Nonopioid Analgesics: Nonsteroidal Anti-Inflammatory Drugs.
Risk of colorectal cancer in patients taking statins and NSAIDS Dr Yana Vinogradova, Prof Julia Hippisley-Cox, Dr Carol Coupland and Prof Richard Logan.
An epidemiologic perspective on etoricoxib David J. Graham, MD, MPH Office of Surveillance and Epidemiology April 12, 2007.
Cardiovascular Risk and NSAIDs Arthritis Advisory Committee Meeting November 29, 2006 Sharon Hertz, M.D. Deputy Director Division of Analgesia, Anesthesia,
CHEMISTRY 4000 Problem Set #1: Rofecoxib (aka Vioxx ® ) Fall 2012 Dr. Susan Findlay.
Some naturally occurring fatty acids in animals
Cardiovascular Risk and NSAIDs Arthritis Advisory Committee Meeting April 12, 2007 Sharon Hertz, M.D. Deputy Director Division of Analgesia, Anesthesia,
Kaplan-Meier analysis of time to recurrent congestive heart failure or death in patients prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory.
Summary Pattern of Specific COX II Inhibitors Use Physician prescribed appropriate COX II use in high risk was 40.08% and inappropriate COX II use in low.
- nonsteroidal anti-inflammatory drugs (NSAIDs), are used to combat inflammation. - Their antiinflammatory action equals that of aspirin. - have analgesic.
NSAIDs: Risk of acute MI compared with remote use Largest NSAID database study ever casts doubt on entire coxib controvers [Rheumawire > News; Jun 10,
Small Bowel Toxicity of Nonselective NSAIDs Revealed by Capsule Endoscopy: Results From a Pivotal Clinical Trial Glenn M. Eisen, M.D., M.P.H. Associate.
Hot Topic Presentation Lars Halford, GP ST3 March 2010
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NSAIDS – Efficacy and Safety Expert speaker.
Date of download: 5/29/2016 From: Statins and Cognitive Function: A Systematic Review Ann Intern Med. 2013;159(10): doi: /
Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Risk of Bleeding With Dabigatran in Atrial Fibrillation.
Severity of Diabetes Mellitus and Risk of Total Hip or Knee Replacement: a Population Based Case-Control Study Methods We performed a population based.
NSAIDS NOTES and Tables
NHS Specialist Pharmacy Service NSAIDS – efficacy and safety Expert speaker Slide set Key content from the NPC NSAIDS QIPP slides is gratefully acknowledged.
Tumor necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis The Annals of the.
The PRECISION Trial Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen Steven E. Nissen MD MACC Disclosure Study.
PRECISION-ABPM Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen Ambulatory Blood Pressure Measurement Trial.
Chapter 71 Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Rachel Kim, PharmD Candidate Cone Health Family Medicine
Cyclooxygenase Inhibitors: Nonsteroidal Anti-Inflammatory Drugs and Acetaminophen 1.
Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis.
Copyright © 2000 American Medical Association. All rights reserved.
The PRECISION Trial Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen or Naproxen Steven E. Nissen MD MACC Disclosure Study.
From: Statins and Cognitive FunctionA Systematic Review
NSAIDS NOTES and Tables
Copyright © 2007 American Medical Association. All rights reserved.
Legend Suppl Fig.1- Risk of COPD according to plasma levels of C-reactive protein (CRP) among never smokers (A) and ever smokers (B). Multiple adjustment.
Selection of NSAIDs for Osteoarthritis
Volume 120, Issue 3, Pages (February 2001)
NSAIDs: Risk of acute MI compared with remote use
Update on NSAID Use:.
Do NSAIDs Affect Longitudinal Changes in Knee Cartilage Volume and Knee Cartilage Defects in Older Adults?  Changhai Ding, MD, Flavia Cicuttini, PhD,
PRECISION Trial design: Patients with arthritis and increased cardiovascular risk were randomized to celecoxib 100 mg twice daily (n = 8,072) vs. ibuprofen.
OTC NSAID Use in Patients With OA and CV Disease
Volume 387, Issue 10033, Pages (May 2016)
Hippisley-Cox J, Coupland C. BMJ 2010;340:c2197
Nonsteroidal anti-inflammatory drug gastropathy
Gastrointestinal Effects of NSAIDs and Coxibs
Wesley T. O’Neal et al. JACEP 2016;2:
Aneurysmal disease is associated with lower carotid intima-media thickness than occlusive arterial disease  Koen M. van de Luijtgaarden, MD, Erik J. Bakker,
Number of patients who received at least one prescription for a COX-2 inhibitor or NSAID after hospital discharge Drug Patients % of study cohort Rofecoxib.
Update on OTC Pain Relievers for Osteoarthritis
NSAIDs Epidemiology NSAIDs amounts to 3.8 of all prescriptions
Influenza Vaccination Rates in Adults with Psoriasis Compared to Adults with Other Chronic Diseases  Megan H. Noe, Daniel B. Shin, Rebecca A. Hubbard,
Treating Osteoarthritis
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
Results of Searches and Screening of Potentially Relevant Studies
Adjusted HRs (95% CIs) for all-cause mortality associated with BMI by smoking status in men and women and by CHD, type 2 diabetes, and cancer status at.
Presentation transcript:

Odds ratios for use of NSAIDs within previous three months compared with controls Drug used within 3 months of index date Adjusted odds ratio* p Celecoxib 1.21 0.11** Rofecoxib 1.32 0.005 Other selective NSAIDs 1.27 0.046 Ibuprofen 1.24 <0.001 Diclofenac 1.55 Naproxen 0.04 Other nonselective NSAIDs 0.03 *Compared with no use of drug in past 3 years (odds ratio 1.00). Adjusted simultaneously for each NSAID, use of aspirin, statin, tricyclic antidepressant, selective serotonin reuptake inhibitor, ischemic heart disease, diabetes, hypertension, osteoarthritis, rheumatoid arthritis, smoking, obesity, and deprivation. **Hippisley-Cox told heartwire the numbers of patients on celecoxib were low and "therefore we probably didn't have sufficient power to look at this drug." Hippisley-Cox J and Coupland C. BMJ 2005; 330:1366-1369. Further calls to reconsider CV safety of all NSAIDs [Rheumawire > News; Jun 9, 2005]